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Summary
Background: Epidemiological surveillance of HIV-1 subtypes is an important and ongoing element
of preparation for global antiviral interventions.
Objective: To assess the molecular epidemiology of HIV-1 in Istanbul, Turkey.
Study design: 27 HIV/AIDS patients were investigated. Data on age, sex, country of birth, and HIV
acquisition route were collected. Following amplification with PCR the sequences of the gp41
region of the env gene were determined using a 310 DNA sequencer (ABI prism, Foster City, USA)
and phylogenetically analyzed.
Results: Among the 27 patients (26 adults and 1 infant), 22 were male, born in Turkey, and 20
infected through heterosexual contact. Two patients acquired the virus through blood and/or
blood transfusion and one infant by vertical transmission. The distribution of the subtypes was as
follows: four were subtype A, 19 subtype B, one subtype C, one subtype D, and two subtype F1.
According to our results, although the B subtype is still predominant, non-B subtypes are also
present, even though the number of registered HIV/AIDS patients is low.
Conclusion: These are the first subtyped HIV-1 strains in Turkey where a low level of HIV
prevalence has been observed since the first reported case in 1985. These findings and Turkey’s
specific geographic localization indicate the need for a nationwide surveillance to detect all
subtypes including the new recombinant ones.
# 2006 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights
reserved.* Corresponding author. Tel.: +90 212 4143000/22462;
fax: +90 212 6322122.
E-mail address: yilmazgu@istanbul.edu.tr (G. Yılmaz).
1201-9712/$32.00 # 2006 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2005.06.011Introduction
Human immunodeficiency virus type 1 (HIV-1) is character-
ized by a very high genetic diversity. This genetic hetero-
geneity is due to the error-prone reverse transcriptase, thePublished by Elsevier Ltd. All rights reserved.
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Table 3 The HIV genotypes of 27 patients
Genotype Number
A 4
B 19
C 1
D 1
F1 2a
a One Russian sex worker and one high-risk sexual contact with a
foreign partner.
Table 1 Age distribution of the patients
Age Number
Younger than 1 year 1
20—30 years 6
30—40 years 11
40—50 years 3
50—60 years 2
Older than 60 years 4
Table 2 Distribution of the 19 HIV/AIDS patients with gen-
otype B according to HIV acquisition route
HIV acquisition route Number
Heterosexual contact 11
HIV-positive partner 1
Infant of an infected mother 1
Blood transfusion 2
Not defined 4rapid turnover of HIV-1 in vivo, recombination, and selective
immune pressures by the host. It is divided into three main
groups: M (major), O (outlier), and N (non-M, non-O-new).
Group M, which includes the great majority of HIV isolates is
divided into at least nine genetic subtypes (A—D, F—H, J and
K) and at least 15 major circulating recombinant forms
(CRFs). The second group, O, is composed of highly divergent
HIV-1 strains. New strains isolated from Cameroonian
patients have recently been classified in the group N.
The extraordinary variability of HIV has led to the devel-
opment and geographical distribution of various distinctive
clades or subtypes of the virus. Although data are limited, HIV
clades and subtypes may have inherent resistance against
certain classes of antiretroviral drugs. Viral fitness and there-
fore viral kinetics may vary between HIV subtypes and may
also influence drug sensitivity of the virus. Some subtypes
have been found to be associated with rapid progression to
resistance under antiretroviral therapy. So the importance of
the epidemiological surveillance of HIV-1 subtypes cannot be
denied.1—7 The objective of the study was to assess the
molecular epidemiology of HIV-1 in Istanbul, Turkey.
Material and methods
We investigated 27 HIV/AIDS patients. Data on age, sex,
country of birth, and HIV acquisition route were collected.
DNA was extracted from uncultured peripheral blood lym-
phocytes by using a QIAmp DNA mini kit according to the
manufacturer’s protocol (Qiagen, Hilden, Germany).
Nested PCR with the CDC HIV-1 primer sets (gp40F1,
gp41R1 and gp46F2, gp47R2) for HIV-1 group M, N, and O
strains were used to amplify a 460 bp-long part of the
gp41 region of the env gene. For reverse transcription
and primary PCR the primers were gp40F1 (forward primer:
50tcttaggagcagcaggaagcactatggg) and gp41R1 (reverse
primer: 50aacgacaaaggtgagtatccctgcctaa). For the nested
PCR the primers were gp46F2 (forward primer:
50acaattattgtctggtatagtgcaacagca) and gp47R2 (reverse
primer: 50ttaaacctatcaagcctcctactatcatta). After initial
denaturation at 94 8C for 2 min, 35 cycles of PCR were
performed. Each cycle consisted of denaturation at 94 8C
for 30 s, annealing at 50 8C for 30 s and extension at 72 8C
for 60 s, with a final extension at 72 8C for 5 min. For
nested PCR the PCR mixtures were subjected to 35 cycles
under the same conditions as the primary PCR.8—11
The PCR product was subjected to cycle-sequencing using
a big-dye terminator kit and sequenced bidirectionally using
an ABI prism 310 sequencer (Applied Biosystems, Foster City,
USA). Traces were assembled and edited on GeneStudio Pro
Contig editor (GeneStudio Inc., GA, USA). Sequences were
aligned by using Clustal W 1.83. Gaps and ambiguous posi-
tions were removed resulting in an alignment of 366 nt
sequences and phylogenetic trees were constructed with
the neighbor-joining method. Distances for neighbor-joining
trees were computed with the correction for multiple sub-
stitutions using a maximum-likelihood model implemented in
Phylip version 3.5 c contained in the GeneStudio package.12
Recombination analysis was performed using Simplot
2.5 software13 along with comparisons to recombinant
sequences. The standard sequences were obtained from
the NIH full-length sequences.Results
Most of the patients (18 of 27) were under 40 years of age; the
age distribution of patients is given in Table 1. Among the 27
patients (26 adults and 1 newborn), 22 were male, born in
Turkey, and 20 were infected through heterosexual contact.
Two patients acquired the virus through blood and/or blood
transfusion and one was the child of an infected woman
(Table 2). The distribution of the subtypes was as follows:
four were subtype A, 19 subtype B, one subtype C, one
subtype D and two subtype F1 (Table 3, Figure 1). Non-B
subtypes were all Turkish except for one Russian who had
acquired the infection through heterosexual contact.
Discussion
Developed countries conduct a systematic surveillance of HIV
genetic variability to inform vaccine research and develop-
ment and to determine whether currently approved assays
for HIV are capable of detecting all circulating strains. Since
the first reported cases of HIV/AIDS in the early 1980s, HIV has
emerged as one of the most significant infectious agents
infecting over 65 million people worldwide so far. Human
immunodeficiency viruses are divided into two types, HIV-1
and HIV-2. The most widely spread, and the main causative
agent of AIDS, is HIV-1.14
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Figure 1 Phylogenetic analysis of HIV strains isolated in Istanbul. Phylogenetic trees were constructed by using the neighbor-joining
method, which was implemented with the Phylip version 3.5 c package. Although the tree drawn using all our samples and prototypes
has low bootstrap values, when each sample is analyzed separately along with the prototypes, bootstrap values were obtained that
support the tree topology.
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total number of reported HIV positive and AIDS cases reached
1515 in the period 1985 to the end of 2002. In fact, by
considering patterns in other countries, HIV positivity is
expected to be much higher than the reported cases. There
has been one reported case of HIV-2 infection acquired as a
result of a renal transplantation in Bombay.15,16
Geographically Turkey is in both the East European and
Central Asian regions and borders countries where reported
rates of curable STIs, and the probability of HIV infection
being transmitted through unprotected sex, are high. Most of
the HIV/AIDS cases reported so far are due to sexual trans-
mission and intravenous drug use.17 In our 27 genotyped
patients, 20 of the HIV-1 cases were due to heterosexual
contact.
Viruses of the M group are responsible for the AIDS pan-
demic. HIV-1 subtype B viruses were responsible from the first
epidemic in North America, Europe, and Australia, and the
metropolitan centers of other continents. Subtype E is the
most prevalent in Thailand and Southern Asia. Subtype F has
been found in Brazil and Romania and G is prevalent in Russia.
Subtype D is limited to Africa. Almost all HIV-1 subtypes are
found in sub-Saharan Africa with subtypes A, C, D, and CRFs
(especially CRF02_AG) being the most prevalent in this con-
tinent. Subtype C is also frequently found in India. Another
often-encountered CRF in Southeast Asia is CRF01_AE.
According to recent investigations, a substantial fraction
of novel HIV-1 infections in various European countries is due
to non-B subtypes and this fraction is likely to grow in the
future.1—7 Our results show that although subtype B is still
predominant, non-B subtypes are also present even though
the number of genotyped HIV/AIDS patients is low. Nineteen
of the 27 patients were subtype B, whereas four were subtype
A, one subtype C, one subtype D and two subtype F1.
Approximately 300 000 immigrants arrive annually in Tur-
key, especially from countries of the Middle East and the
Balkans. Also the number of foreign students, especially from
Africa, is not negligible. Turkey is an attractive country with
regard to sex tourism for its northern neighbors where sub-
types F and C are predominant. So the low proportion of
subtypes other than B, especially C and F is somewhat
surprising.
Viral divergence is created by point mutations and more
strikingly by recombination. The co-existence of several
genetic HIV-1 subtypes within a population increases the
possibility of a dual infection and in this way the possibility
for inter-subtype recombination. Large-scale screening and
investigation of full-length genomes have led to the discov-
ery of new subtypes as well as inter-subtype recombinant
virus genomes. Consequences for the biological properties of
the divergent viruses are not fully understood. Recombina-
tion is a frequent phenomenon especially in Africa. In Cyprus
and Greece CRFs have been detected and in Greece they
account for approximately 2% of the total HIV-1 infected
individuals.3—18 Although we performed analysis with Sim-
plot, as only a small region of the gp41 was investigated in
this study, we are not able to comment on the absence of
CRFs.
Since in western countries the predominant subtype is B,
current antiretroviral treatment regimens are designed and
fine-tuned for use against this subtype. Transmission of sub-
type B in countries where antiretroviral therapy is widelyused is declining, but resistant strains are emerging due to
the selective pressure of therapy. Despite the predominance
of subtype B, the presence of other subtypes in our small
study population and the geographic bridging position of
Turkey underline the need for regular, effective and smart
nationwide surveillance. The scarcity of antiretroviral drugs
and problems in therapy adherence may favor antiretroviral
resistance in Turkey. Considering all of the above, and the
possibility of diverse drug susceptibility patterns between
HIV subtypes, the genotypic surveillance in our country is
critically important.
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